Life sciences employers have been impacted by various market forces in the last several years, and the recent economic turbulence is only adding to the challenges they face.
Many employers in this space have implemented, or are considering, reductions in force (RIFs) to meet these headwinds. Indeed, one industry source cataloged 187 layoffs among biotech companies in 2024—a 57 percent jump compared to 119 layoffs in 2022. That trend appeared to accelerate in the first quarter of 2025, as that same industry source tallied sixty-seven layoffs. A leading consulting firm noted that 30 percent of life sciences senior executives surveyed would focus on cost-cutting initiatives in 2025, including layoffs.
Life sciences employers planning RIFs may want to develop a planning matrix that addresses key employment law compliance issues, as well as considerations that are specific to the industry. This article provides an overview.
DENVER | One of the nation’s most prominent election conspiracy theorists, MyPillow founder Mike Lindell, stuck by his false claims that the 2020 presidential election was stolen while testifying ...